EDWARD HERBERT ABRAHAM, M.D.
Radiology at 81 St, Tulsa, OK
License number
Oklahoma 78272
Category
Radiology
Type
Radiation Oncology
License number
Oklahoma E-8136
Category
Radiology
Type
Radiation Oncology
License number
Oklahoma 25750
Category
Radiology
Type
Radiation Oncology
Address
Address
2
2408 E 81St St SUITE 110, Tulsa, OK 74137
587 Hanover Center Rd, Hanover, NH 03755
587 Hanover Center Rd, Hanover, NH 03755
Phone
(918) 388-2300
(918) 388-2301 (Fax)
(603) 252-9102
(918) 388-2301 (Fax)
(603) 252-9102
Personal information
See more information about EDWARD HERBERT ABRAHAM at radaris.comName
Address
Phone
587 Hanover Center Rd, Hanover, NH 03755
2 Picadilly Cir, Londonderry, NH 03053
8 Ferson Rd, Hanover, NH 03755
13 Fletcher Cir, Hanover, NH 03755
587 Hanover Center Rd, Hanover, NH 03755
Professional information
See more information about EDWARD HERBERT ABRAHAM at trustoria.com
Dr. Edward H Abraham, Tulsa OK - MD (Doctor of Medicine)
Dr. Edward H Abraham, Tulsa OK - MD (Doctor of Medicine)
Specialties:
Oncology
Address:
Cancer Treatment Centers of America at Southwestern Regional Medical Center
10109 E 79Th St, Tulsa 74133
(800) 524-4632 (Phone)
10109 E 79Th St, Tulsa 74133
(800) 524-4632 (Phone)
Languages:
English
Hospitals:
Cancer Treatment Centers of America at Southwestern Regional Medical Center
10109 E 79Th St, Tulsa 74133
Hillcrest Hospital - Claremore
1202 North Muskogee Pl, Claremore 74017
10109 E 79Th St, Tulsa 74133
Hillcrest Hospital - Claremore
1202 North Muskogee Pl, Claremore 74017
Education:
Medical School
Harvard Medical School
Graduated: 1978
Children S Hospital Boston
Massachusetts General Hospital, Radiation Oncology
Harvard Medical School
Graduated: 1978
Children S Hospital Boston
Massachusetts General Hospital, Radiation Oncology
Labeled Adenosine For Use In Positron Emission Tomography
Labeled Adenosine For Use In Positron Emission Tomography
US Patent:
8420049, Apr 16, 2013
Filed:
Feb 17, 2012
Appl. No.:
13/399642
Inventors:
Edward H. Abraham - Hanover NH, US
International Classification:
A61K 51/00, A61M 36/14
US Classification:
424 111, 424 181
Abstract:
Radiolabeled adenosine or radiolabeled adenosine containing molecules for use in positron emission tomography for assessing alterations in adenylate metabolism in a patient are provided.
Labeled Adenosine For Use In Positron Emission Tomography
Labeled Adenosine For Use In Positron Emission Tomography
US Patent:
2005024, Nov 3, 2005
Filed:
Nov 22, 2004
Appl. No.:
10/995061
Inventors:
Edward Abraham - Hanover NH, US
International Classification:
A61K051/00, C07F005/00, C07D473/12, C07H019/04
US Classification:
424001110, 534011000, 544277000, 536026100
Abstract:
Radiolabeled adenosine or radiolabeled adenosine containing molecules for use in positron emission tomography for assessing alterations in adenylate metabolism in a patient are provided.
Method Of Treating Bone Metastasis
Method Of Treating Bone Metastasis
US Patent:
7148210, Dec 12, 2006
Filed:
Oct 15, 2003
Appl. No.:
10/687102
Inventors:
Edward H. Abraham - Hanover NH, US
Assignee:
Trustees of Dartmouth College - Hanover NH
International Classification:
A61K 31/675
US Classification:
514 79, 514 81, 514 82
Abstract:
The invention provides a drug combination for the treatment of diseases associated with bone metastasis. The combination provides adenosine or a derivative thereof, a bisphosphonate, and a targeting agent(s) to decrease the signs or symptoms associated with such diseases.